DuChemBio Surges on Expectations for Lilly's Alzheimer's Drug Approval
Predicted impact: Low· Actual: +28.5% vs sector, volume 19.2× normal (5 trading days)
Same Lilly approval expectation story as earlier item; repeat of the same news.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.